微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 39.93% | -12.15% | -22.67% | 94/158 | 32.3% | 艾力斯 | 96.74% | 行业排名> |
| 2024-12-31 | 51.63% | -7.63% | 0.77% | 76/158 | 51.8% | 首药控股 | 98.96% | 行业排名> |
| 2024-09-30 | 51.24% | 1.23% | 4.68% | 74/158 | 22.73% | 迪哲医药 | 97.73% | 行业排名> |
| 2024-06-30 | 48.95% | -10.95% | 7.69% | 79/158 | 33.18% | 百利天恒 | 97.99% | 行业排名> |
| 2024-03-31 | 45.45% | -19.19% | -18.68% | 85/158 | 51.56% | 百利天恒 | 98.92% | 行业排名> |
| 2023-12-31 | 55.89% | -21.53% | 10.43% | 67/158 | 51.38% | 迈威生物 | 98.93% | 行业排名> |
| 2023-09-30 | 50.61% | -31.19% | -7.92% | 75/158 | 32.56% | 迈威生物 | 99.59% | 行业排名> |
| 2023-06-30 | 54.96% | -24.31% | -2.27% | 67/158 | 38.45% | 迈威生物 | 99.8% | 行业排名> |
| 2023-03-31 | 56.24% | -27.56% | -21.04% | 63/158 | 52.78% | 迈威生物 | 99.46% | 行业排名> |
| 2022-12-31 | 71.23% | -8.83% | -3.16% | 37/158 | 53.66% | 迈威生物 | 99.75% | 行业排名> |
| 2022-09-30 | 73.55% | 2% | 1.28% | 35/158 | 6.2% | 迈威生物 | 99.67% | 行业排名> |
| 2022-06-30 | 72.62% | -12.27% | -6.47% | 37/158 | 21.37% | 迈威生物 | 99.44% | 行业排名> |
| 2022-03-31 | 77.64% | 2% | -0.62% | 27/158 | 54.28% | 迈威生物 | 98.57% | 行业排名> |
| 2021-12-31 | 78.13% | -4.16% | -5.61% | 29/158 | 55.1% | 首药控股 | 99.93% | 行业排名> |
| 2021-06-30 | 82.77% | 2% | 1.54% | 19/158 | 47.23% | 艾力斯 | 99.41% | 行业排名> |
| 2020-12-31 | 81.52% | 31.38% | 31.38% | 20/158 | -145.9% | 艾力斯 | 98.7% | 行业排名> |
| 2019-12-31 | 62.05% | 23.55% | 23.55% | 54/158 | -1222.98% | 艾力斯 | 99.4% | 行业排名> |
| 2018-12-31 | 50.22% | 2% | 2% | 70/158 | -208.09% | 首药控股 | 99.94% | 行业排名> |